HALO Halozyme Therapeutics 8-K2021Halozyme Provides 2021 Financial Guidance Highlighted by Strong Revenue and Eps Growth
11 Jan 21
Files
SEC
Content Analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
|
|
HALO 8-K Filings
- 13 Jan 21 Results of Operations and Financial Condition
- 11 Jan 21 Halozyme Provides 2021 Financial Guidance Highlighted by Strong Revenue and Eps Growth
- 2 Nov 20 Halozyme Reports Third Quarter 2020 Results and Raises Full Year 2020 Guidance
- 10 Aug 20 Halozyme Reports Significant Recent Achievements and Second Quarter 2020 Results
- 11 May 20 Halozyme Reports First Quarter 2020 Results
Filing View
Search this filing
Table of Contents
Get all this for free
- Email alerts for new filings that match keywords or companies
- Plot, compare & download financial data
- 10-K & 10-Q redlined comparisons
- Advanced filing search & analysis
- Sentiment analysis for financial filings
- Favorites, search history, and more…